Delivery Order SPE2DR25D6028-SPE2DR26FASEB
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $20,375.92 for the Menveo vaccine (5-dose vial) by the Defense Logistics Agency's Medical Supply Chain on August 20, 2025. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of September 17, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $146,369.15 delivery order to AmerisourceBergen Drug Corp for Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML meningococcal vaccine, with an ultimate completion date of November 26, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, awarded competitively on November 25, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a $45,143 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Menveo 1 vial combination vaccine (A-C-Y-W-135) in 0.5ML format. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 24, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $12,548.56 to AmerisourceBergen Drug Corp for the supply of Menveo vaccine on November 10, 2025. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 9, 2025. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that...
- The Defense Logistics Agency awarded a $45,609.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the Menveo vaccine (5-dose vial) on October 20, 2025, with an ultimate completion date of October 21, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The contract was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a $152,714.53 delivery order to AmerisourceBergen Drug Corp for Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML vaccine products, with an ultimate completion date of July 28, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being performed in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $6,822.77 for Menveo 1 Vial (meningococcal vaccine combination) on December 2, 2025, with an ultimate completion date of December 3, 2025. This is a firm fixed-price, non-set-aside delivery order for pharmaceutical supply to support federal medical procurement needs. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $53,326.80 delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Menveo vaccine (5-dose vials) with an ultimate completion date of November 24, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a child delivery order, this award falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $13,397.27 on August 12, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine. This firm fixed price delivery order, with an ultimate completion date of August 13, 2025, carries no set-aside designation and represents a competitively awarded transaction. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $7,290.30 on September 25, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML vaccine product. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of September 26, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's broader Indefinite...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FASEBDelivery Order
The Defense Logistics Agency (DLA) awarded a $12,746.62 delivery order to AmerisourceBergen Drug Corp for Menveo vaccine (5-dose vials) on December 1, 2025, with completion targeted for December 2, 2025. This is a firm fixed-price, non-set-aside contract performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child order under AmerisourceBergen's substantial $999.99 billion Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which runs through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that supplies an extensive range of medications, vaccines, and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates significant capability in fulfilling competitive medical procurement requirements across multiple therapeutic domains. This Menveo vaccine delivery order exemplifies the company's role as a primary supplier within DLA's pharmaceutical distribution network, supporting military and veteran healthcare needs through its established prime vendor relationship.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.7k | 11/30/25 |